---
title: "Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer | IMUX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287754776.md"
description: "Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer | IMUX Stock News"
datetime: "2026-05-27T02:30:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287754776.md)
  - [en](https://longbridge.com/en/news/287754776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287754776.md)
---

# Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer | IMUX Stock News

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer | IMUX Stock News

### Related Stocks

- [IMUX.US](https://longbridge.com/en/quote/IMUX.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Immunic names CEO Erik Lundgren to board after Tamar Howson retirement resignation](https://longbridge.com/en/news/291840871.md)
- [Immunic Updates Corporate Strategy, Highlights Vidofludimus Plans](https://longbridge.com/en/news/292732048.md)
- [Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium | IMUX Stock News](https://longbridge.com/en/news/278536359.md)
- [Immunic Buy Rating: Vidofludimus Calcium’s Differentiated Efficacy and Safety Profile vs. BTK Inhibitors in Relapsing MS](https://longbridge.com/en/news/283709394.md)
- [Immunic rises after $400M private placement, leadership transition](https://longbridge.com/en/news/275911243.md)